BioCentury
ARTICLE | Top Story

Sanofi, DiCE form discovery collaboration

March 17, 2016 1:04 AM UTC

Sanofi (Euronext:SAN; NYSE:SNY) and DiCE Molecules SV LLC (Redwood City, Calif.) entered a five-year collaboration on Wednesday to co-develop small molecules against up to 12 targets using DiCE's small molecule screening methods.

DiCE uses DNA-driven small molecule synthesis and directed evolution on a microfluidic platform to identify rare drug leads from large chemical libraries. In the collaboration, the companies hope to use small molecules to target protein-protein interfaces in disease areas of interest to Sanofi. ...